Ptprd ligands for stimulant and opiate use disorders

Ended Cooperative Agreement Awarded Last action

Award ID
U01DA047713
Recipient
Awarding agency
Obligated
$8,457,901

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date
Originally
Funding
  • $6,624,870.00 Federal
  • $1,833,031.00 Non-federal
Place of performance
New Mexico, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$296,250 $0
Amendment -$296,250 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment Ptprd ligands for stimulant and opiate use disorders - pathological TAU hyperphosphorylation and neurofibrillary pathology are major alzheimer's disease (ad)… $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment Alzheimer's disease PYGSK3 pathophysiology and ptprd positive allosteric modulators $349,443 $0
Amendment $349,443 $0
Amendment $349,443 $349,443
Amendment $1,483,588 $0
Amendment $1,483,588 $1,483,588
Amendment $315,055 $0
Amendment $153,126 $0
Amendment $1,378,147 $0
Original award $1,355,537 $0
Show all 19

Quick answers

Who received award U01DA047713?

U01DA047713 was awarded to Biomedical Research Institute Of New Mexico by National Institute on Drug Abuse (National Institutes of Health) on January 1, 2019.

How much is award U01DA047713 worth?

$8,457,901 has been obligated on U01DA047713: $6,624,870 in federal funding and $1,833,031 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award